STRM Insider Trading Activity and SEC Form 4 Filings
STRM insider trading summary
No open-market insider purchases or sales of Streamline Health Solutions Inc. (STRM) have been reported on SEC Form 4 in the past 12 months.
Latest STRM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 20, 2024 | Benjamin Louis Stilwill | President and CEO | Buy | $1K (6,300 @ $0.16) |
| Oct 26, 2022 | Kenan Lucas | Director | Buy | $1000K (757,575 @ $1.32) |
| Dec 16, 2021 | Kenan Lucas | Director | Buy | $150K (100,000 @ $1.50) |
| Mar 2, 2021 | Tamarack Capital GP, LLC | 10% Owner | Buy | $1.0M (625,000 @ $1.60) |
| Mar 2, 2021 | Tamarack Global Healthcare Fund QP, L.P. | Insider | Buy | $1.0M (625,000 @ $1.60) |
| Mar 2, 2021 | Tamarack Capital Management, LLC | 10% Owner | Buy | $1.0M (625,000 @ $1.60) |
| Mar 2, 2021 | Tamarack Advisers, LP | 10% Owner | Buy | $1.0M (625,000 @ $1.60) |
| Mar 2, 2021 | Tamarack Global Healthcare Fund, L.P. | 10% Owner | Buy | $1.0M (625,000 @ $1.60) |
| Jan 16, 2020 | David Driscoll | Insider | Sell | $35K (26,213 @ $1.32) |
| Oct 16, 2019 | Judith Starkey | Director | Buy | $102K (100,000 @ $1.02) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.